{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:39:21Z","timestamp":1792798761699,"version":"4.5.0"},"reference-count":201,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nanomaterials"],"abstract":"<jats:p>Cancer remains a major global health challenge, characterized by abnormal cell growth and metastasis. Current limitations of conventional therapies, particularly non-specific toxicity harming healthy cells, highlight the need for more targeted approaches. Nanotechnology offers a revolutionary solution, utilizing nanoparticles (NPs) for precise drug delivery to tumor sites while minimizing off-target effects. These nanometer-scale particles enable superior binding to cancer cell membranes, the tumor microenvironment, or nuclear receptors, facilitating significantly higher local concentrations of therapeutic agents. NPs, synthesized via physical, chemical, or biological methods, are categorized as organic (organic material-based) or inorganic (metallic particle-based). Key delivery mechanisms include the Enhanced Permeability and Retention (EPR) effect and Active Transport and Retention (ATR). This review specifically examines NP applications for the most prevalent cancers in the US (2025): breast, prostate, and lung. Gold and magnetic NPs show significant promise for early breast cancer detection. For lung cancer, polymeric NPs like PCL, PLA, and PLGA are effective carriers for peptides, proteins, and nucleic acids. BIND-014, a docetaxel-loaded NP formulation, represents an emerging strategy for prostate cancer. Clinically established examples include liposomal doxorubicin and albumin-bound paclitaxel. We comprehensively discuss the synthesis methods, delivery mechanisms, and the current landscape of NPs in research and clinical trials for these cancers. This analysis underscores the potential of nanotechnology to provide more effective and targeted therapeutic options for cancer patients in the future. A distinctive feature of this review is its comparative cancer-specific analysis of NP platforms in breast, prostate, and lung cancers. Unlike previous generalized reviews, this work integrates synthesis strategies, delivery mechanisms, translational challenges, and clinically relevant formulations to provide a bench-to-bedside perspective on the future of nanomedicine in oncology.<\/jats:p>","DOI":"10.3390\/nano16090515","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:40:12Z","timestamp":1777981212000},"page":"515","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nanoparticles: An Emerging Hope in Cancer Therapy"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2765-3269","authenticated-orcid":false,"given":"Shahid","family":"Sher","sequence":"first","affiliation":[{"name":"Department of Microbiology and Cell Science, University of Florida, Gainesville, FL 32611, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosny","family":"Jean","sequence":"additional","affiliation":[{"name":"School of the Environment, Florida Agricultural and Mechanical University, Tallahassee, FL 32307, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5880-1095","authenticated-orcid":false,"given":"Zaman","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Biological and Environmental Sciences, Faculty of Sciences, Emerson University Multan, Multan 60760, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.clinthera.2016.03.026","article-title":"Current challenges in cancer treatment","volume":"38","author":"Zugazagoitia","year":"2016","journal-title":"Clin. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-pathol-012615-044438","article-title":"Cancer stem cells: Basic concepts and therapeutic implications","volume":"11","author":"Nassar","year":"2016","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/mco.2021.2433","article-title":"General insight into cancer: An overview of colorectal cancer","volume":"15","author":"Alzahrani","year":"2021","journal-title":"Mol. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S481","DOI":"10.4103\/0973-1296.168976","article-title":"Selective cytotoxicity and pro-apoptotic activity of stem bark of Wrightia tinctoria (Roxb.) R. Br. in cancerous cells","volume":"11","author":"Chaudhary","year":"2015","journal-title":"Pharmacogn. Mag."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5306\/wjco.v7.i1.54","article-title":"Historical review of the causes of cancer","volume":"7","author":"Blackadar","year":"2016","journal-title":"World J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/bjc.1953.8","article-title":"A new theory on the cancer-inducing mechanism","volume":"7","author":"Nordling","year":"1953","journal-title":"Br. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: Statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","article-title":"Planning for tomorrow: Global cancer incidence and the role of prevention 2020\u20132070","volume":"18","author":"Soerjomataram","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"105599","DOI":"10.1016\/j.jddst.2024.105599","article-title":"Nanoparticles in cancer diagnosis and treatment: Progress, challenges, and opportunities","volume":"95","author":"Rashidi","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acs.molpharmaceut.8b00810","article-title":"Gold nanoparticles in cancer treatment","volume":"16","author":"Sztandera","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(18)32252-9","article-title":"GLOBOCAN 2018: Counting the toll of cancer","volume":"392","author":"Lancet","year":"2018","journal-title":"Lancet"},{"key":"ref_13","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chavda, V.P., Balar, P.C., Teli, D., Davidson, M., Bojarska, J., and Apostolopoulos, V. (2023). Antibody\u2013biopolymer conjugates in oncology: A review. Molecules, 28.","DOI":"10.3390\/molecules28062605"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","article-title":"Nanodrug delivery","volume":"27","author":"Nakamura","year":"2016","journal-title":"Bioconjug Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s40005-025-00731-z","article-title":"Disulfide bond-driven nanoassembly of lipophilic epirubicin prodrugs for breast cancer therapy","volume":"55","author":"Yuan","year":"2025","journal-title":"J. Pharm. Investig."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"22968","DOI":"10.1021\/acsnano.5c02492","article-title":"Biomimetic ginsenoside Rb1 and probucol co-assembled nanoparticles for targeted atherosclerosis therapy via inhibition of oxidative stress, inflammation, and lipid deposition","volume":"19","author":"Zeng","year":"2025","journal-title":"ACS Nano"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1038\/s41598-025-91420-2","article-title":"A fusion model to predict the survival of colorectal cancer based on histopathological image and gene mutation","volume":"15","author":"He","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s11095-008-9661-9","article-title":"Cancer is a preventable disease that requires major lifestyle changes","volume":"25","author":"Anand","year":"2008","journal-title":"Pharm. Res."},{"key":"ref_21","first-page":"1","article-title":"Therapies in cancer treatment: An overview","volume":"7","author":"Gupta","year":"2015","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/jbiol73","article-title":"How chemotherapy damages the central nervous system","volume":"7","author":"Meyers","year":"2008","journal-title":"J. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1756-8722-4-35","article-title":"Chemotherapy in advanced bladder cancer: Current status and future","volume":"4","author":"Ismaili","year":"2011","journal-title":"J. Hematol. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.radonc.2007.03.001","article-title":"Proton therapy\u2013a systematic review of clinical effectiveness","volume":"83","author":"Olsen","year":"2007","journal-title":"Radiother. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/annonc\/mdf280","article-title":"Heating the patient: A promising approach?","volume":"13","year":"2002","journal-title":"Ann. Oncol."},{"key":"ref_26","unstructured":"Ahmed, S.M. (2019). Patient Care Management of Cancer. [Bachelor\u2019s Thesis, BRAC University]."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Sikora, K. (2020). Scope and limitations of gene therapy. Gene Therapy, Garland Science.","DOI":"10.1201\/9781003076919-1"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1158\/1078-0432.CCR-14-1189","article-title":"Nanotechnology: Future of oncotherapy","volume":"21","author":"Gharpure","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.apsb.2024.12.007","article-title":"Recent advances in the bench-to-bedside translation of cancer nanomedicines","volume":"15","author":"Liu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.crhy.2011.06.001","article-title":"Nanomedicine, nanotechnology in medicine","volume":"12","author":"Boisseau","year":"2011","journal-title":"Comptes Rendus Phys."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-3-030-76263-6_3","article-title":"Nano-oncology: Clinical application for cancer therapy and future perspectives","volume":"2","author":"Singh","year":"2021","journal-title":"Cancer Nanotheranostics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"214636","DOI":"10.1016\/j.bioadv.2025.214636","article-title":"Enhanced permeability and retention (EPR) effect: Advances in nanomedicine for improved tumor targeting","volume":"181","author":"Khan","year":"2025","journal-title":"Biomater. Adv."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Vagena, I.A., Malapani, C., Gatou, M.A., Lagopati, N., and Pavlatou, E.A. (2025). Enhancement of EPR effect for passive tumor targeting: Current status and future perspectives. Appl. Sci., 15.","DOI":"10.3390\/app15063189"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1002\/jps.21270","article-title":"Nanovehicular intracellular delivery systems","volume":"97","author":"Prokop","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1038\/s41467-025-63726-2","article-title":"Protein corona formed on lipid nanoparticles compromises delivery efficiency of mRNA cargo","volume":"16","author":"Voke","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Mayordomo, N.M., Zatarain-Beraza, A., Valerio, F., \u00c1lvarez-M\u00e9ndez, V., Turegano, P., Herranz-Garc\u00eda, L., and Fanarraga, M.L. (2025). The protein corona paradox: Challenges in achieving true biomimetics in nanomedicines. Biomimetics, 10.","DOI":"10.3390\/biomimetics10050276"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"114154","DOI":"10.1016\/j.jconrel.2025.114154","article-title":"Customization of protein corona to reprogram cancer nanomedicines: Mechanistic insights and therapeutic implications","volume":"386","author":"Lu","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s11671-021-03628-6","article-title":"Nanoparticles for cancer therapy: Current progress and challenges","volume":"16","author":"Gavas","year":"2021","journal-title":"Nanoscale Res. Lett."},{"key":"ref_39","first-page":"2502","article-title":"A review on nanoparticles: Their synthesis and types","volume":"2277","author":"Hasan","year":"2015","journal-title":"Res. J. Recent Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"13611","DOI":"10.1073\/pnas.96.24.13611","article-title":"Silver-based crystalline nanoparticles, microbially fabricated","volume":"96","author":"Klaus","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jbiotec.2006.11.014","article-title":"Bioreductive deposition of platinum nanoparticles on the bacterium Shewanella algae","volume":"128","author":"Konishi","year":"2007","journal-title":"J. Biotechnol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/adma.200501865","article-title":"Growing metal nanoparticles by enzymes","volume":"18","author":"Willner","year":"2006","journal-title":"Adv. Mater."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.matlet.2006.07.042","article-title":"Biological synthesis of silver nanoparticles using the fungus Aspergillus flavus","volume":"61","author":"Vigneshwaran","year":"2007","journal-title":"Mater. Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nmat1152","article-title":"Biological synthesis of triangular gold nanoprisms","volume":"3","author":"Shankar","year":"2004","journal-title":"Nat. Mater."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"454090","DOI":"10.4061\/2011\/454090","article-title":"Biosynthesis of silver nanoparticles from Desmodium triflorum","volume":"2011","author":"Ahmad","year":"2011","journal-title":"Biotechnol. Res. Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2010.02.001","article-title":"Biological synthesis of metal nanoparticles by microbes","volume":"156","author":"Narayanan","year":"2010","journal-title":"Adv. Colloid Interface Sci."},{"key":"ref_47","first-page":"162","article-title":"Biosynthesis of metal nanoparticles using fungi and actinomycete","volume":"85","author":"Sastry","year":"2003","journal-title":"Curr. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1038\/s41598-021-81701-x","article-title":"PGMD\/curcumin nanoparticles for the treatment of breast cancer","volume":"11","author":"Kumari","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-024-01889-y","article-title":"Current advance of nanotechnology in diagnosis and treatment for malignant tumors","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/jcp.29126","article-title":"Nanoparticles and cancer therapy","volume":"235","author":"Dolati","year":"2020","journal-title":"J. Cell Physiol."},{"key":"ref_51","first-page":"133","article-title":"Drug delivery and nanoparticles","volume":"3","author":"Borm","year":"2008","journal-title":"Int. J. Nanomed."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/wnan.72","article-title":"Multifunctional imaging nanoprobes","volume":"2","author":"Jarzyna","year":"2010","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1369-7021(10)70142-5","article-title":"Nanotechnology tools in pharmaceutical R&D","volume":"12","author":"Kumar","year":"2010","journal-title":"Mater. Today"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/138920012798356899","article-title":"The ligand nanoparticle conjugation approach for targeted cancer therapy","volume":"13","author":"Karra","year":"2012","journal-title":"Curr. Drug Metab."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.arabjc.2017.05.011","article-title":"Nanoparticles: Properties, applications and toxicities","volume":"12","author":"Khan","year":"2019","journal-title":"Arab. J. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","article-title":"Smart nanoparticles for cancer therapy","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_57","first-page":"184","article-title":"Polymeric nanoparticles based topical gel","volume":"6","author":"Elmowafy","year":"2017","journal-title":"Beni-Suef Univ. J. Basic. Appl. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jconrel.2015.10.006","article-title":"Control of polymeric nanoparticle size","volume":"219","author":"Hickey","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.2147\/IJN.S46900","article-title":"Nanopharmaceuticals (part 1)","volume":"9","author":"Weissig","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0169-409X(96)00401-2","article-title":"Polymeric micelles as new drug carriers","volume":"21","author":"Kwon","year":"1996","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/sj.bjc.6602204","article-title":"Phase I clinical trial of NK911","volume":"91","author":"Matsumura","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/1097-0142(20010501)91:9<1826::AID-CNCR1203>3.0.CO;2-J","article-title":"Phase I study of liposomal doxorubicin","volume":"91","author":"Hong","year":"2001","journal-title":"Cancer"},{"key":"ref_63","first-page":"139","article-title":"Dendrimers in drug delivery","volume":"6","author":"Madaan","year":"2014","journal-title":"J. Pharm. Bioallied Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2018.12.080","article-title":"Lipids and polymers in pharmaceutical technology","volume":"558","author":"Siepmann","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/1389557517666170512095151","article-title":"Dendrimers: General aspects","volume":"18","author":"Mariyam","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/adma.200300010","article-title":"Vesicles and liposomes","volume":"15","author":"Antonietti","year":"2003","journal-title":"Adv. Mater."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1021\/jz200007h","article-title":"Polymersomes spanning from nano-to microscales","volume":"2","author":"Meng","year":"2011","journal-title":"J. Phys. Chem. Lett."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1039\/c1py00061f","article-title":"Polymeric vesicles in biomedical applications","volume":"2","author":"Brinkhuis","year":"2011","journal-title":"Polym. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jconrel.2011.10.005","article-title":"Polymersomes for drug delivery","volume":"161","author":"Lee","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Eltaib, L. (2025). Polymeric nanoparticles in targeted drug delivery: Unveiling the impact of polymer characterization and fabrication. Polymers, 17.","DOI":"10.3390\/polym17070833"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1039\/D5NR00071H","article-title":"Characterisation of polymeric nanoparticles for drug delivery","volume":"17","author":"Floyd","year":"2025","journal-title":"Nanoscale"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1002\/mog2.67","article-title":"Advances and applications of nanoparticles in cancer therapy","volume":"3","author":"Huang","year":"2024","journal-title":"MedComm\u2013Oncology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.3390\/ma3021420","article-title":"Self-assembled hydrogel nanoparticles","volume":"3","author":"Pereira","year":"2010","journal-title":"Materials"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.1021\/acs.jafc.8b01052","article-title":"Recent advances in edible polymer-based hydrogels","volume":"66","author":"Ali","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1021\/acs.biomac.6b01604","article-title":"Hydrogels for therapeutic delivery","volume":"18","author":"Buwalda","year":"2017","journal-title":"Biomacromolecules"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nbt929","article-title":"Quantum dot ligands provide new insights","volume":"22","author":"Lidke","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nmat1390","article-title":"Quantum dot bioconjugates for imaging","volume":"4","author":"Medintz","year":"2005","journal-title":"Nat. Mater."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1016\/j.biomaterials.2007.07.014","article-title":"Biological applications of quantum dots","volume":"28","author":"Jamieson","year":"2007","journal-title":"Biomaterials"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejpb.2009.11.003","article-title":"Cyclodextrin-based nanosponges","volume":"74","author":"Swaminathan","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"100011","DOI":"10.1016\/j.nxbio.2025.100011","article-title":"Recent advances in the nanoparticle-based targeted cancer treatment: A review","volume":"2","author":"Uddin","year":"2026","journal-title":"Next Bioeng."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1021\/nl071546n","article-title":"Quantum dot\u2014Aptamer conjugates for cancer","volume":"7","author":"Bagalkot","year":"2007","journal-title":"Nano Lett."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3390\/cancers3032888","article-title":"Nanotechnology-based detection","volume":"3","author":"Mousa","year":"2011","journal-title":"Cancers"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrc3180","article-title":"Treating metastatic cancer with nanotechnology","volume":"12","author":"Schroeder","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41417-018-0017-2","article-title":"Magnetic nanoparticle-mediated gene therapy","volume":"25","author":"Basoglu","year":"2018","journal-title":"Cancer Gene Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/jop.12921","article-title":"Targeted magnetic nanoparticle hyperthermia","volume":"48","author":"Legge","year":"2019","journal-title":"J. Oral Pathol. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nmat3792","article-title":"Strategies for advancing cancer nanomedicine","volume":"12","author":"Chauhan","year":"2013","journal-title":"Nat. Mater."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/17425247.2014.955011","article-title":"Development of next-generation macromolecular drugs","volume":"12","author":"Nakamura","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2011.09.063","article-title":"Drug targeting to tumors","volume":"161","author":"Lammers","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s44222-024-00154-9","article-title":"Mechanisms of nanoparticle delivery","volume":"2","author":"Nguyen","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/acs.accounts.9b00228","article-title":"Survey of clinical translation of cancer nanomedicines","volume":"52","author":"He","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.015","article-title":"To exploit the tumor microenvironment","volume":"244","author":"Danhier","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2017.07.030","article-title":"The drug delivery field at the inflection point","volume":"267","author":"Park","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"12281","DOI":"10.1021\/acsnano.9b09713","article-title":"What went wrong with anticancer nanomedicine","volume":"14","author":"Sun","year":"2020","journal-title":"ACS Nano"},{"key":"ref_94","first-page":"95","article-title":"Chemotherapeutic experiments on rat tumors","volume":"1","author":"Weil","year":"1916","journal-title":"J. Cancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0014-2964(73)90142-4","article-title":"Uptake of labelled proteins in rat tumour","volume":"9","author":"Peterson","year":"1973","journal-title":"Eur. J. Cancer"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/000331976701800201","article-title":"Vascular permeability in experimental brain tumors","volume":"18","author":"Wright","year":"1967","journal-title":"Angiology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0001-2998(78)80028-2","article-title":"Mechanisms of localization of gallium-67","volume":"8","author":"Larson","year":"1978","journal-title":"Semin. Nucl. Med."},{"key":"ref_98","first-page":"3348","article-title":"Quantitation of fibrinogen influx","volume":"44","author":"Dvorak","year":"1984","journal-title":"Cancer Res."},{"key":"ref_99","first-page":"2115","article-title":"Use of oily contrast medium for drug targeting","volume":"44","author":"Iwai","year":"1984","journal-title":"Cancer Res."},{"key":"ref_100","first-page":"3352","article-title":"Mirovascular permeability of stealth liposomes","volume":"54","author":"Yuan","year":"1994","journal-title":"Cancer Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e1519","DOI":"10.1002\/wnan.1519","article-title":"Strategies to improve tumor penetration","volume":"11","author":"Zhang","year":"2019","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3892\/mco.2014.356","article-title":"Passive targeting of nanoparticles to cancer","volume":"2","author":"Bazak","year":"2014","journal-title":"Mol. Clin. Oncol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.phrs.2010.03.005","article-title":"Targeting nanoparticles to cancer","volume":"62","author":"Wang","year":"2010","journal-title":"Pharmacol. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.msec.2019.01.066","article-title":"Employment of EPR effect","volume":"98","author":"Kalyane","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles","volume":"9","author":"Petros","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"Entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"key":"ref_107","first-page":"596","article-title":"Pathways of macromolecular tracer transport","volume":"67","author":"Kohn","year":"1992","journal-title":"Lab. Investig."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1172\/JCI92284","article-title":"Tumor-penetrating peptide enhances transcytosis","volume":"127","author":"Liu","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s41563-023-01630-0","article-title":"Exit of nanoparticles from solid tumours","volume":"22","author":"Nguyen","year":"2023","journal-title":"Nat. Mater."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s44222-024-00203-3","article-title":"Nanoparticle delivery to tumours: From EPR and ATR mechanisms to clinical impact","volume":"2","author":"Dasgupta","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"114614","DOI":"10.1016\/j.addr.2022.114614","article-title":"The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives","volume":"191","author":"Sun","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/clinchem\/hvad202","article-title":"Epidemiology of cancer","volume":"70","author":"Schwartz","year":"2024","journal-title":"Clin. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"111898","DOI":"10.1016\/j.eurpolymj.2023.111898","article-title":"Emerging application of magnetic nanoparticles","volume":"187","author":"Dongsar","year":"2023","journal-title":"Eur. Polym. J."},{"key":"ref_114","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast and ovarian cancer","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/jama.2011.1590","article-title":"Moderate alcohol consumption and breast cancer risk","volume":"306","author":"Chen","year":"2011","journal-title":"JAMA"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1470-2045(06)70793-8","article-title":"Nanoparticles in diagnosis of breast cancer","volume":"7","author":"Yezhelyev","year":"2006","journal-title":"Lancet Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/1078-0432.CCR-07-1441","article-title":"Therapeutic nanoparticles for drug delivery","volume":"14","author":"Cho","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3390\/cancers2041884","article-title":"Nanoparticles in sentinel lymph node assessment","volume":"2","author":"Johnson","year":"2010","journal-title":"Cancers"},{"key":"ref_120","first-page":"738","article-title":"Magnetic nanoparticles in diagnosis","volume":"7","author":"Wu","year":"2017","journal-title":"Mol. Clin. Oncol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s00330-015-3852-7","article-title":"Polymer film-nanoparticle composites","volume":"26","author":"Kaplan","year":"2016","journal-title":"Eur. Radiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.ijbiomac.2017.03.137","article-title":"Artemisinin loaded chitosan magnetic nanoparticles","volume":"104","author":"Natesan","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/107327481001700305","article-title":"Review of triple-negative breast cancer","volume":"17","author":"Bui","year":"2010","journal-title":"Cancer Control"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s10904-017-0758-7","article-title":"Tamoxifen loaded magnetic nanoparticles","volume":"28","author":"Nosrati","year":"2018","journal-title":"J. Inorg. Organomet. Polym. Mater."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12645-021-00086-8","article-title":"Breast cancer drug delivery by chitosan nanoparticles","volume":"12","author":"Taherian","year":"2021","journal-title":"Cancer Nanotechnol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2217\/nnm-2019-0428","article-title":"L-carnosine from magnetic nanoparticles","volume":"15","author":"Farid","year":"2020","journal-title":"Nanomedicine"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"111452","DOI":"10.1016\/j.msec.2020.111452","article-title":"Disulfiram-loaded magnetic nanoparticles","volume":"119","author":"Solak","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0167-7322(99)00088-4","article-title":"Synthesis of aqueous magnetic liquids","volume":"83","author":"Fauconnier","year":"1999","journal-title":"J. Mol. Liq."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.nano.2009.04.002","article-title":"Multifunctional magnetic nanoparticles","volume":"6","author":"Kumar","year":"2010","journal-title":"Nanomedicine"},{"key":"ref_130","first-page":"228","article-title":"Magnetic nanoparticles coated by 5-FU","volume":"497","author":"Jamili","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: Advances and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.biopha.2014.08.013","article-title":"Idarubicin-loaded folic acid magnetic nanoparticles","volume":"68","author":"Gunduz","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1080\/03639045.2018.1451881","article-title":"PAMAM-modified magnetic nanoparticles","volume":"44","author":"Nosrati","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1470-2045(02)00818-5","article-title":"Hyperthermia in combined treatment","volume":"3","author":"Wust","year":"2002","journal-title":"Lancet Oncol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2217\/nnm.13.146","article-title":"Thermal potentiation of chemotherapy","volume":"8","author":"Rinaldi","year":"2013","journal-title":"Nanomedicine"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"105601","DOI":"10.1088\/0957-4484\/27\/10\/105601","article-title":"Evaluation of targeting SPIONs\u2013PEG\u2013HER","volume":"27","author":"Almaki","year":"2016","journal-title":"Nanotechnology"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3109\/02656736.2013.845801","article-title":"Comparison of magnetic nanoparticle and microwave","volume":"29","author":"Petryk","year":"2013","journal-title":"Int. J. Hyperth."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014The first FDA-approved nano-drug","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1158\/1078-0432.CCR-07-4592","article-title":"Pharmacokinetic study of nab-paclitaxel","volume":"14","author":"Gardner","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1158\/1078-0432.CCR-04-2291","article-title":"Clinical pharmacokinetics of ABI-007","volume":"11","author":"Sparreboom","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","article-title":"Phase III trial of nab-paclitaxel","volume":"23","author":"Gradishar","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41416-018-0235-2","article-title":"Safety of MM-302 in breast cancer patients","volume":"119","author":"Munster","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.nano.2014.04.003","article-title":"Study of nanoparticle conjugate CRLX101","volume":"10","author":"Gaur","year":"2014","journal-title":"Nanomedicine"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2011.03.007","article-title":"Clinical development of CRLX101","volume":"153","author":"Svenson","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1158\/0008-5472.CAN-15-3435","article-title":"Preclinical efficacy of bevacizumab with CRLX101","volume":"76","author":"Pham","year":"2016","journal-title":"Cancer Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"P3-10-04","DOI":"10.1158\/1538-7445.SABCS14-P3-10-04","article-title":"Genexol\u00ae-PM vs conventional paclitaxel","volume":"75","author":"Ro","year":"2015","journal-title":"Cancer Res."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Pradhan, R., Dey, A., Taliyan, R., Puri, A., Kharavtekar, S., and Dubey, S.K. (2023). Targeted nanocarriers for TNBC. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15010246"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/64.1.4","article-title":"A short history of lung cancer","volume":"64","author":"Witschi","year":"2001","journal-title":"Toxicol. Sci."},{"key":"ref_149","unstructured":"Henschke, C.I., McCarthy, P., and Wernick, S. (2003). Lung Cancer: Myths, Facts, Choices, WW Norton & Co."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1378\/chest.111.6.1710","article-title":"Revisions in staging lung cancer","volume":"111","author":"Mountain","year":"1997","journal-title":"Chest"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jconrel.2012.05.029","article-title":"Self-assembled glycol chitosan nanogels","volume":"161","author":"Lee","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/S0142-9612(00)00115-0","article-title":"Manufacturing techniques of PLGA devices","volume":"21","author":"Jain","year":"2000","journal-title":"Biomaterials"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2010.12.006","article-title":"Gene complex powder for inhalation","volume":"150","author":"Okamoto","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"11913","DOI":"10.1158\/0008-5472.CAN-06-2066","article-title":"Dendrimer-encapsulated camptothecins","volume":"66","author":"Morgan","year":"2006","journal-title":"Cancer Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1021\/mp9001393","article-title":"MRI-visible micellar nanomedicine","volume":"7","author":"Guthi","year":"2010","journal-title":"Mol. Pharm."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1016\/j.biomaterials.2012.05.026","article-title":"Liposomes for oral delivery of paclitaxel","volume":"33","author":"Jain","year":"2012","journal-title":"Biomaterials"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1002\/chem.200800114","article-title":"A new photothermal therapeutic agent","volume":"14","author":"Hu","year":"2008","journal-title":"Chem. Eur. J."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/mp060132k","article-title":"Methotrexate conjugated to gold nanoparticles","volume":"4","author":"Chen","year":"2007","journal-title":"Mol. Pharm."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/smll.200500360","article-title":"Smart magnetic silica nanomaterials","volume":"2","author":"Yoon","year":"2006","journal-title":"Small"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1080\/095530099139322","article-title":"Chemical toxicity of actinides and lanthanides","volume":"75","author":"Fritsch","year":"1999","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"325102","DOI":"10.1088\/0957-4484\/18\/32\/325102","article-title":"Detectable carboxylated nanodiamond","volume":"18","author":"Liu","year":"2007","journal-title":"Nanotechnology"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"9480","DOI":"10.1021\/nn202410f","article-title":"Targeted delivery of cisplatin to lung cancer","volume":"5","author":"Peng","year":"2011","journal-title":"ACS Nano"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1039\/C1NR11132A","article-title":"Multifunctional ferritin cage nanostructures","volume":"4","author":"Li","year":"2012","journal-title":"Nanoscale"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbrc.2004.04.067","article-title":"Incorporation of biodegradable nanoparticles","volume":"318","author":"Brzoska","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_165","first-page":"2293","article-title":"Suppression of lung cancer progression","volume":"7","author":"Hong","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cac2.12225","article-title":"Paclitaxel liposome versus gemcitabine","volume":"42","author":"Zhang","year":"2022","journal-title":"Cancer Commun."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jamaoncol.2018.2168","article-title":"BIND-014 for patients with mCRPC","volume":"4","author":"Autio","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"809-e765","DOI":"10.1093\/oncolo\/oyac155","article-title":"Results of NC-6300 (nanoparticle epirubicin)","volume":"27","author":"Riedel","year":"2022","journal-title":"Oncologist"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"945","DOI":"10.2147\/IJN.S435407","article-title":"SN38 drug delivery system in cancer","volume":"19","author":"Qi","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"120099","DOI":"10.1016\/j.carbon.2025.120099","article-title":"ROS-responsive SN38 prodrug nanoparticles","volume":"233","author":"Qin","year":"2025","journal-title":"Carbon"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Liu, Y., Dai, X., Jiang, S., Qahar, M., Feng, C., Guo, D., Wang, L., Ma, S., and Huang, L. (2022). Targeted co-delivery of gefitinib and rapamycin. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23148025"},{"key":"ref_172","unstructured":"Luque-Michel, E. (2019). Imaging and Therapy of Brain Cancer Using Theranostic Nanoparticles. [Ph.D. Thesis, Universidad de Navarra]."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.maturitas.2012.01.016","article-title":"Nanoparticle therapeutics for prostate cancer","volume":"73","author":"Sanna","year":"2012","journal-title":"Maturitas"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrc2641","article-title":"Cancer prevention by tea","volume":"9","author":"Yang","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.phymed.2009.09.011","article-title":"Green tea polyphenols for chemoprevention","volume":"17","author":"Johnson","year":"2010","journal-title":"Phytomedicine"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1158\/0008-5472.CAN-08-3978","article-title":"Introducing nanochemoprevention","volume":"69","author":"Siddiqui","year":"2009","journal-title":"Cancer Res."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1021\/jm1013715","article-title":"Delivery of EGCG to prostate cancer cells","volume":"54","author":"Sanna","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1073\/pnas.0502101102","article-title":"Crystal structure of PSMA","volume":"102","author":"Davis","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2217\/nnm.10.101","article-title":"EGCG-loaded polysaccharide nanoparticles","volume":"6","author":"Rocha","year":"2011","journal-title":"Nanomedicine"},{"key":"ref_180","first-page":"1119","article-title":"Delivery of curcumin in prostate cancer","volume":"32","author":"Thangapazham","year":"2008","journal-title":"Int. J. Oncol."},{"key":"ref_181","first-page":"1","article-title":"Docetaxel-loaded nanoparticles for prostate cancer","volume":"6","author":"Sanna","year":"2011","journal-title":"Nanoscale Res. Lett."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/pros.20576","article-title":"Delivery of suicide DNA to prostate tumors","volume":"67","author":"Peng","year":"2007","journal-title":"Prostate"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1158\/0008-5472.CAN-06-2731","article-title":"Anti-HER2 cationic immunoemulsion","volume":"67","author":"Goldstein","year":"2007","journal-title":"Cancer Res."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3109\/02656736.2010.485593","article-title":"Thermal therapy for prostate cancer","volume":"26","author":"Krishnan","year":"2010","journal-title":"Int. J. Hyperth."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1158\/1078-0432.CCR-15-2548","article-title":"Phase I study of PSMA-targeted docetaxel-containing nanoparticle BIND-014 in patients with advanced solid tumors","volume":"22","author":"Mita","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_186","unstructured":"Thaxton, C.S., Elghanian, R., Thomas, A.D., Stoeva, S.I., Lee, J.-S., Smith, N.D., Schaeffer, A.J., Klocker, H., Horninger, W., and Bartsch, G. (2020). Bio-Barcode Assay. Spherical Nucleic Acids, Jenny Stanford Publishing."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1166\/jbn.2010.1105","article-title":"Detection of prostate cancer cells","volume":"6","author":"Viator","year":"2010","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.eururo.2006.11.023","article-title":"Thermotherapy of prostate cancer","volume":"52","author":"Johannsen","year":"2007","journal-title":"Eur. Urol."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Cruz-Hern\u00e1ndez, C.D., Rodr\u00edguez-Mart\u00ednez, G., Cort\u00e9s-Ram\u00edrez, S.A., Morales-Pacheco, M., Cruz-Burgos, M., Losada-Garc\u00eda, A., Reyes-Grajeda, J.P., Gonz\u00e1lez-Ram\u00edrez, I., Gonz\u00e1lez-Covarrubias, V., and Camacho-Arroyo, I. (2022). Aptamers in prostate cancer. Biomolecules, 12.","DOI":"10.3390\/biom12081056"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Lampe, J.B., Desai, P.P., Tripathi, A.K., Sabnis, N.A., Chen, Z., Ranjan, A.P., and Vishwanatha, J.K. (2023). Cabazitaxel-loaded nanoparticles. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15020662"},{"key":"ref_191","unstructured":"Imberg, K. (2013). RNA Interfference Screen in Prostate Cancer, New York University."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.4161\/hv.29553","article-title":"mRNA vaccine for treatment of prostate cancer","volume":"10","author":"Rausch","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"113991","DOI":"10.1016\/j.jconrel.2025.113991","article-title":"Clinical cancer nanomedicines","volume":"385","author":"Pallares","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40164-025-00602-1","article-title":"Applications of liposomes and lipid nanoparticles in cancer therapy: Current advances and prospects","volume":"14","author":"Cheng","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41423-025-01316-4","article-title":"Eliciting antitumor immunity via therapeutic cancer vaccines","volume":"22","author":"Peng","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Freitas, L.F., Ferreira, A.H., Thipe, V.C., Varca, G.H.C., Lima, C.S.A., Batista, J.G.S., Riello, F.N., Nogueira, K., Cruz, C.P.C., and Mendes, G.O.A. (2021). The state of the art of theranostic nanomaterials for lung, breast, and prostate cancers. Nanomaterials, 11.","DOI":"10.3390\/nano11102579"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/2228-5326-3-45","article-title":"Emerging applications of nanoparticles for lung cancer diagnosis and therapy","volume":"3","author":"Sukumar","year":"2013","journal-title":"Int. Nano Lett."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1186\/s12951-024-02901-x","article-title":"Nanotechnology in healthcare, and its safety and environmental risks","volume":"22","author":"Ma","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1039\/D5LP00154D","article-title":"Nanocarrier strategies for deep tumour penetration","volume":"3","author":"Zhang","year":"2025","journal-title":"RSC Appl. Polym."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01668-1","article-title":"Multifunctional nanoparticle-mediated combining therapy for human diseases","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Nanomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-4991\/16\/9\/515\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:14:49Z","timestamp":1778213689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-4991\/16\/9\/515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":201,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["nano16090515"],"URL":"https:\/\/doi.org\/10.3390\/nano16090515","relation":{},"ISSN":["2079-4991"],"issn-type":[{"value":"2079-4991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]}}}